A pharmaceutical firm’s OTC business unit was stagnating in the US and underperforming internationally, so they turned to Marakon. We designed granular resource allocation strategies to unlock profitable growth in US while turning around Mexico and China businesses. These changes drove double digit top line and >2x EBIT in target regions and ultimately resulted in the sale of the business unit at 100% premium to intrinsic value.
Premier League replica kit: Relevant product markets to assess exclusivity and football club market power
Recent enforcement by the UK competition authority, with clubs fined for price-fixing and existing precedent on exclusive dealing, has not deterred clubs from...